Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Longenecker John P Phd, Director. Insider active across 2 companies, notably Pacira BioSciences, Inc.. Cumulatively, 3 reports have been logged. Split: 1 buy · 0 sell. Activity tracked since 9 June 2021. The latest transaction was disclosed on 3 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
John P. Longenecker, PhD, is a Board Member at Pacira BioSciences, Inc. He brings his expertise in research and development, contributing to the strategic direction of the company. His role is crucial in supporting innovation and growth in the biopharmaceutical sector.